1985
Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2
Berkowitz G, Kelsey J, LiVolsi V, Holford T, Merino M, Ort S, O'Connor T, White C. Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2. Journal Of The National Cancer Institute 1985, 75: 43-50. PMID: 3859695, DOI: 10.1093/jnci/75.1.43.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseBenign breast diseaseBreast diseaseHigher socioeconomic statusOdds ratioLow Quetelet's indexSocioeconomic statusBreast cancer patientsCase-control studyEpidemiologic similaritiesCurrent smokersPostmenopausal womenPremenopausal womenEpithelial atypiaGross cystsFibrocystic diseaseCancer patientsPapillary hyperplasiaQuetelet indexBiopsy specimensRisk factorsSurgical conditionsConnecticut hospitalsLow parityBreast cancerESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN1
BERKOWITZ G, KELSEY J, HOLFORD T, LIVOLSI V, MERINO M, BECK G, ORT S, O'CONNOR T, WHITE C. ESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN1. American Journal Of Epidemiology 1985, 121: 238-245. PMID: 4014118, DOI: 10.1093/oxfordjournals.aje.a113994.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseReplacement therapyPostmenopausal womenHospital-based case-control studyMedical care utilizationPossible risk factorsCase-control studyDuration of useOdds of diseasePostmenopausal women1Care utilizationMenopausal estrogensExcess oddsRisk factorsSurgical conditionsTherapyDiseasePositive associationMore yearsWomenOddsAssociationEstrogen
1984
Exogenous hormone use and fibrocystic breast disease by histopathologic component
Berkowitz G, Kelsey J, Livolsi V, Merino M, Holford T, Hildreth N, Ort S, O'Connor T, White C. Exogenous hormone use and fibrocystic breast disease by histopathologic component. International Journal Of Cancer 1984, 34: 443-449. PMID: 6490201, DOI: 10.1002/ijc.2910340403.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseGross cystsReplacement therapyHospital-based case-control studyExogenous hormone useOral contraceptive usePost-menopausal womenCase-control studyPostmenopausal womenPremenopausal womenHormone useOral contraceptivesEpithelial atypiaControl womenPapillary hyperplasiaBiopsy specimensFibrocystic lesionsSurgical conditionsContraceptive useHistopathologic componentsWomenIncreased occurrenceDisease